3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hodgkin Disease
1
Fatigue
1
Depression
1
Congenital Abnormalities
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
16
fludarabine phosphate
13
Peripheral Blood Stem Cell Transplantation
13
Whole-Body Irradiation
10
Cyclosporine
10
Antilymphocyte Serum
9
Melphalan
8
Busulfan
8
Mycophenolic Acid
7
Filgrastim
6
fludarabine
5
Radiotherapy
5
Methotrexate
5
Etoposide
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cytarabine
4
Carmustine
4
Blood Specimen Collection
4
thymoglobulin
3
Therapeutics
3
Rituximab
3
Flow Cytometry
3
Aprepitant
3
Analgesia
3
Tacrolimus
2
Stem Cell Transplantation
2
Proton Therapy
2
Polymerase Chain Reaction
2
Ondansetron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hodgkin Disease
×
Body Composition
×
Clear all
NCT05188755
2022-12-23
CUPCAKE
University Hospital, Clermont-Ferrand
Phase NA
Completed
44 enrolled